We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology.
Our focus is on innovation in digital healthcare, connected medical devices, and life sciences
We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly.
Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey.
Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution.
Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there.
What do we look for?
Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices
Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy
Founders and teams with domain expertise who seek collaborative investment partners
Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A).
Our investment approach
Our investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs
Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective.
We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world.
We have committed €300M for investments and company creation in digital health and life sciences.
What do we commit to you?
Active and involved healthcare investors who operate with integrity, approachability, and transparency
A team of passionate healthcare and venture capital experts diverse in demographic and experience
A track record of success and experience navigating the ups and downs of early-stage company building
Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare